Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates antiapoptotic and proliferative mechanisms
- 2 August 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 19 (12) , 1752-1754
Abstract
Selective and regulatable expansion of transduced cells could augment gene therapy for many disorders. The activation of modified growth factor receptors via synthetic chemical inducers of dimerization allows for the coordinated growth of transduced cells. This system can also provide information on specific receptor‐mediated signaling without interference from other family members. Although several receptor subunits have been investigated in this context, little is known about the precise molecular events associated with dimerizer‐initiated signaling. We have constructed and expressed an AP20187‐regulated KDR chimeric receptor in human TF1 cells and analyzed activation of this gene switch using functional, biochemical, and microarray analyses. When deprived of natural ligands, GM‐CSF, interleukin‐3, or erythropoietin, AP20187 prevented apoptosis of transduced TF1 cells, induced dose‐dependent proliferation, and supported long‐term growth. In addition, AP20187 stimulation activated the signaling molecules associated with mitogen‐activated protein kinase and phosphatidyl‐inositol 3‐kinase/Akt pathways. Microarray analysis determined that a number of transcripts involved in a variety of cellular processes were differentially expressed. Notably, mRNAs affiliated with heat stress, including Hsp70 and Hsp105, were up‐regulated. Functional assays showed that Hsp70 and Hsp105 protected transduced TF1 cells from apoptosis and premature senescence, in part through regulation of Akt. These observations delineate specific roles for kinase insert domain‐containing receptor, or KDR, signaling and suggest strategies to endow genetically modified cells with a survival advantage enabling the generation of adequate cell numbers for therapeutic outcomes.Keywords
Funding Information
- National Institutes of Health (HL70569, AP20187, pC4Fv1E)
This publication has 65 references indexed in Scilit:
- Cytokine mediated suppression of TF‐1 apoptosis requires PI3K activation and inhibition of Bim expressionFEBS Letters, 2004
- In Vivo Selection of Genetically Modified Erythroid Cells Using a Jak2-Based Cell Growth SwitchMolecular Therapy, 2004
- Vascular Endothelial Growth Factor–Induced Genes in Human Umbilical Vein Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Dimerizer-Induced Proliferation of Genetically Modified HepatocytesMolecular Therapy, 2002
- Control of Myoblast Proliferation with a Synthetic LigandJournal of Biological Chemistry, 2001
- Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic CellsMolecular Therapy, 2000
- Fluorescence Resonance Energy Transfer Reveals Interleukin (IL)-1-dependent Aggregation of IL-1 Type I Receptors That Correlates with Receptor ActivationJournal of Biological Chemistry, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Signal Transduction Through the EGF Receptor Transfected in IL-3-Dependent Hematopoietic CellsScience, 1988
- IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivoCell, 1985